Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marylin Madamet

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
The Journal of Antimicrobial Chemotherapy|May 15, 2020
Baseline and multinormal distribution of ex vivo susceptibilities of Plasmodium falciparum to methylene blue in Africa, 2013-18Mathieu Gendrot, Marylin Madamet, Joel Mosnier, et al.
Infection and Drug Resistance|September 15, 2018
Prevalence of Dominique Fatima Voumbo-Matoumona, Lady Charlène Kouna, Marylin Madamet, et al.
Diagnostics (Basel, Switzerland)|November 11, 2022
Assessment of a Commercial Real-Time PCR Assay (Vitassay qPCR Malaria 5 Test) to Detect Human Malaria Infection in Travelers Returning to FranceMarylin Madamet, Rémy Amalvict, Nicolas Benoit, et al.
Experimental Parasitology|December 27, 2005
Pbcrk-1, the Plasmodium berghei orthologue of P. falciparum cdc-2 related kinase-1 (Pfcrk-1), is essential for completion of the intraerythrocytic asexual cycleRadha Rangarajan, Amy Bei, Natohya Henry, et al.
Antimicrobial Agents and Chemotherapy|February 10, 2016
Delayed Onset of Plasmodium falciparum Malaria after Doxycycline Prophylaxis in a Soldier Returning from the Central African RepublicEmilie Javelle, Marylin Madamet, Tiphaine Gaillard, et al.
Pharmaceutics|August 28, 2021
Prevalence of Mutations in the <i>pfcoronin</i> Gene and Association with Ex Vivo Susceptibility to Common Quinoline Drugs against <i>Plasmodium falciparum</i>Océane Delandre, Mathieu Gendrot, Isabelle Fonta, et al.
Malaria Journal|March 14, 2018
The D113N mutation in the RING E3 ubiquitin protein ligase gene is not associated with ex vivo susceptibility to common anti-malarial drugs in African Plasmodium falciparum isolatesMathieu Gendrot, Francis Tsombeng Foguim, Marie Gladys Robert, et al.
Phytotherapy Research : PTR|July 14, 2017
Stephanine from Stephania venosa (Blume) Spreng Showed Effective Antiplasmodial and Anticancer Activities, the Latter by Inducing Apoptosis through the Reverse of Mitotic ExitPhuong Mai Le, Vandana Srivastava, Thanh Tam Nguyen, et al.
Malaria Journal|June 7, 2020
Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolatesFrancis Tsombeng Foguim, Hervé Bogreau, Mathieu Gendrot, et al.
Emerging Infectious Diseases|April 19, 2016
Plasmodium falciparum In Vitro Resistance to Monodesethylamodiaquine, Dakar, Senegal, 2014Bécaye Fall, Marylin Madamet, Cheikhou Camara, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
The Journal of Antimicrobial Chemotherapy|May 15, 2020
Baseline and multinormal distribution of ex vivo susceptibilities of Plasmodium falciparum to methylene blue in Africa, 2013-18Mathieu Gendrot, Marylin Madamet, Joel Mosnier, et al.
Infection and Drug Resistance|September 15, 2018
Prevalence of Dominique Fatima Voumbo-Matoumona, Lady Charlène Kouna, Marylin Madamet, et al.
Diagnostics (Basel, Switzerland)|November 11, 2022
Assessment of a Commercial Real-Time PCR Assay (Vitassay qPCR Malaria 5 Test) to Detect Human Malaria Infection in Travelers Returning to FranceMarylin Madamet, Rémy Amalvict, Nicolas Benoit, et al.
Experimental Parasitology|December 27, 2005
Pbcrk-1, the Plasmodium berghei orthologue of P. falciparum cdc-2 related kinase-1 (Pfcrk-1), is essential for completion of the intraerythrocytic asexual cycleRadha Rangarajan, Amy Bei, Natohya Henry, et al.
Antimicrobial Agents and Chemotherapy|February 10, 2016
Delayed Onset of Plasmodium falciparum Malaria after Doxycycline Prophylaxis in a Soldier Returning from the Central African RepublicEmilie Javelle, Marylin Madamet, Tiphaine Gaillard, et al.
Pharmaceutics|August 28, 2021
Prevalence of Mutations in the <i>pfcoronin</i> Gene and Association with Ex Vivo Susceptibility to Common Quinoline Drugs against <i>Plasmodium falciparum</i>Océane Delandre, Mathieu Gendrot, Isabelle Fonta, et al.
Malaria Journal|March 14, 2018
The D113N mutation in the RING E3 ubiquitin protein ligase gene is not associated with ex vivo susceptibility to common anti-malarial drugs in African Plasmodium falciparum isolatesMathieu Gendrot, Francis Tsombeng Foguim, Marie Gladys Robert, et al.
Phytotherapy Research : PTR|July 14, 2017
Stephanine from Stephania venosa (Blume) Spreng Showed Effective Antiplasmodial and Anticancer Activities, the Latter by Inducing Apoptosis through the Reverse of Mitotic ExitPhuong Mai Le, Vandana Srivastava, Thanh Tam Nguyen, et al.
Malaria Journal|June 7, 2020
Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolatesFrancis Tsombeng Foguim, Hervé Bogreau, Mathieu Gendrot, et al.
Emerging Infectious Diseases|April 19, 2016
Plasmodium falciparum In Vitro Resistance to Monodesethylamodiaquine, Dakar, Senegal, 2014Bécaye Fall, Marylin Madamet, Cheikhou Camara, et al.
Pageof 4